For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a curative treatment ...
Newswise — PHOENIX — A Mayo Clinic-led international phase 3 study found that a new immunotherapy helped many patients with an aggressive form of bladder cancer keep their bladder instead of having it ...
At 2 years, metastasis-free survival was 81% and overall survival was 83%. HealthDay News — Pembrolizumab combined with gemcitabine-based chemoradiation is feasible and effective in patients with ...
A new immunotherapy helped many patients with an aggressive form of bladder cancer ‌avoid surgical removal of their bladders in a late-stage trial. The treatment kept many patients cancer-free for ...